IP Library Granted Patent US 9,066,934
Granted Patent B2
US 9,066,934 · App. 13/809,855 · Granted Jun 30, 2015

Composite material comprising pectin and calcium phosphate and method for its realisation

Inventors: Paola Petrini (Milan, IT); Maria Cristina Tanzi (Milan, IT); Liliana Giuliano (Casteltermini, IT); Fabiola Munarin (Giussano, IT); Pierfrancesco Robotti (Nago-Torbole, IT); Giacomo Bianchi (Borgo Valsugana, IT)
Assignee: EUROCOATING S.P.A.
A61K33/42A61L27/425
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,066,934
App. No.
13/809,855
Granted
Jun 30, 2015
Kind
B2
Abstract

A method for obtaining a composite material including an aqueous solution of pectin and a suspension/solution of calcium phosphate mixed together, wherein said solution of pectin cross-links with a portion of the calcium obtained from the solution of calcium phosphate and wherein a portion of the calcium phosphate in suspension remains as inorganic phase and composite materials obtained by this method.

Claims (16)

1. A composite biocompatible gel material comprising an aqueous solution of pectin and a solution/suspension of calcium phosphate mixed together, wherein in said gel material the concentration of pectin is greater than the concentration of calcium phosphate, and wherein said gel material further comprises said pectin cross-linked with at least one portion of calcium phosphate and at least one second portion of calcium phosphate trapped to form an inorganic phase of calcium phosphate.

2. The composite biocompatible gel material according to claim 1 , wherein said calcium phosphate is present in the aqueous solution at a concentration of between 0.1 and 10% weight/volume and said pectin is present in the aqueous solution at a concentration between 0.2 and 10% weight/volume.

3. The composite biocompatible gel material according to claim 1 , wherein said pectin has a percentage of esterification of between 5% and 50%.

4. The composite biocompatible gel material according to claim 1 , wherein said percentage of esterification is at least one of 42% or 40%.

5. The composite biocompatible gel material according to claim 1 , wherein said pectin has a molecular weight between 40 and 350 kDa.

6. The composite biocompatible gel material according to claim 1 , wherein said pectin has a molecular weight between 15 and 1000 kDa.

7. The composite biocompatible gel material according to claim 1 , wherein said calcium phosphate is present in solution/suspension at a concentration of between 0.25% and 5% weight/volume.

8. The composite biocompatible gel material according to claim 1 , wherein said solution/suspension includes calcium phosphate at a concentration of between 0.25% and 3%.

9. The composite biocompatible gel material according to claim 1 , wherein said calcium phosphate comprises at least one of the following types: calcium phosphate Ca3(PO4)2, calcium dihydrogen phosphate Ca(H2PO4)2, calcium hydrogen phosphate CaHPO4, tricalcium phosphate β or α Ca3(PO4)2, tetracalcium phosphate Ca4(PO4)2, hydroxyapatite Ca10(PO4)6(OH)2, acid calcium phosphate, calcium glycerophosphate, calcium lactophosphate, tribasic calcium phosphate, calcium o-phosphate and calcium pyrophosphate.

10. The composite biocompatible gel material according to claim 1 , wherein said composite material includes equal portions of the solution of pectin and of said solution/suspension of calcium phosphate mixed together.

11. The composite biocompatible gel material according to claim 1 , wherein said composite material includes from 0.2 parts to 2 parts of said solution of pectin, and one part of said solution/suspension of calcium phosphate.

12. The composite biocompatible gel material according to claim 1 , comprising mannitol.

13. The composite biocompatible gel material according to claim 12 , wherein said mannitol has a final concentration of between 50 and 500 mM.

14. The composite biocompatible gel material according to claim 12 , wherein said mannitol has a final concentration of 220 mM.

15. The composite biocompatible gel material according to claim 1 , wherein said material is loaded with active substances against the reduction of the infection, including metal ions known for antibacterial effectiveness and/or topical antimicrobial drugs and/or wherein said calcium phosphate is pre-loaded with said metal ions known for their antibacterial effectiveness, including silver or zinc and/or wherein said pectin is suitable for conveying drugs and/or specific medicinal substances.

16. The composite biocompatible gel material obtainable according to claim 1 , for use in medical applications as a medicine for aesthetic applications and/or treatment of skin lesions and/or for the treatment of cartilage defects and/or as a bone substitute.

Assignments (3)
CHANGE OF NAME Recorded Sep 11, 2020
From: EUROCOATING S.P.A.
To: LINCOTEK TRENTO S.P.A.
Reel/Frame 053755/0084 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 11, 2014
From: EUROCOATING S.P.A.; POLITECNICO DI MILANO
To: EUROCOATING S.P.A.
Reel/Frame 033294/0752 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 28, 2013
From: PETRINI, PAOLA; TANZI, MARIA CRISTINA; GIULIANO, LILIANA; MUNARIN, FABIOLA; ROBOTTI, PIERFRANCESCO; BIANCHI, GIACOMO
To: EUROCOATING S.P.A.; POLITECNICO DI MILANO
Reel/Frame 030109/0517 →
Priority Claims (1)
IT VR2010A0140 · Jul 13, 2010 · national
Continuity (1)
Related Publication 20130177656A1 · Jul 11, 2013